T. Rowe Price Associates’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $210K | Buy |
|
|||||
|
2025
Q2 | $220K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $44K | Sell |
|
|||||
|
2024
Q3 | $48K | Hold |
|
|||||
|
2024
Q2 | $268K | Sell |
|
|||||
|
2024
Q1 | $184K | Buy |
|
|||||
|
2023
Q4 | $256K | Buy |
|
|||||
|
2023
Q3 | $325K | Buy |
|
|||||
|
2023
Q2 | $632K | Buy |
|
|||||
|
2023
Q1 | $373K | Sell |
|
|||||
|
2022
Q4 | $938K | Sell |
|
|||||
|
2022
Q3 | $595K | Sell |
|
|||||
|
2022
Q2 | $42.3M | Buy |
|
|||||
|
2022
Q1 | $110M | Buy |
|
|||||
|
2021
Q4 | $72.9M | Buy |
|
|||||
|
2021
Q3 | $76.7M | Sell |
|
|||||
|
2021
Q2 | $188M | Sell |
|
|||||
|
2021
Q1 | $256M | Buy |
|
|||||
|
2020
Q4 | $254M | Buy |
|
|||||
|
2020
Q3 | $220M | Buy |
|